Get started
Author

Toshiki Terao

Observed names: T Terao, T. Terao
Observed institutions: Okayama University, Okayama University Hospital, Kameda Medical Center, Iwakuni Medical Center, National Cancer Center Hospital East, Okayama City Hospital
ORCID: 0000-0002-6728-3346
Observed ORCID: 0000-0002-6728-3346
OpenAlex ID: A5018322845
A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling
2022 · Yoshiaki Abe, Mamiko Sakata-Yanagimoto, et al. · Nature Cell Biology · 103
PDF
Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment
2019 · Toshiki Terao, Yosuke Minami · Cells · 55
PDF
Pre‐treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron‐emission tomography/computed tomography variables for outcome prediction in patients with newly diagnosed multiple myeloma in clinical practice
2020 · Toshiki Terao, Youichi Machida, et al. · British Journal of Haematology · 36
PDF
Multiple myeloma with t(11;14)‐associated immature phenotype has lower CD38 expression and higher BCL2 dependence
2021 · Akihiro Kitadate, Toshiki Terao, et al. · Cancer Science · 30
Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure
2021 · Ayumi Kuzume, Rikako Tabata, et al. · British Journal of Haematology · 28
Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host disease
2024 · Yui Kambara, Hideaki Fujiwara, et al. · Blood · 20
PDF
Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma
2021 · Toshiki Terao, Youichi Machida, et al. · European Radiology · 20
Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML
2022 · Toshiki Terao, Ken-ichi Matsuoka, et al. · Blood Advances · 19
Antibody response to COVID-19 vaccination in patients with lymphoma
2022 · Kentaro Narita, So Nakaji, et al. · International Journal of Hematology · 19
PDF
Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
2022 · Takafumi Tsushima, Toshiki Terao, et al. · International Journal of Hematology · 18
PDF
Fatal thrombotic microangiopathy with rhabdomyolysis as an initial symptom after the first dose of mRNA–1273 vaccine: A case report
2022 · Yuya Kamura, Toshiki Terao, et al. · International Journal of Infectious Diseases · 18
PDF
Negative Prognostic Impact of High-Dose or Long-Term Corticosteroid Use in Patients with Relapsed or Refractory B-Cell Lymphoma Who Received Tisagenlecleucel
2023 · Toshiki Terao, Wataru Kitamura, et al. · Transplantation and Cellular Therapy · 16
Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature review
2022 · Toshiki Terao, Takafumi Tsushima, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 16
Prognostic Impact of Metabolic Heterogeneity in Patients With Newly Diagnosed Multiple Myeloma Using 18F-FDG PET/CT
2021 · Toshiki Terao, Youichi Machida, et al. · Clinical Nuclear Medicine · 16
Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease
2022 · Masatoshi Matsunami, Tomo Suzuki, et al. · Renal Replacement Therapy · 14
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma
2022 · Toshiki Terao, Takeshi Yamashita, et al. · International Journal of Hematology · 14
PDF
Depletion of CD38 ‐positive regulatory T cells by anti‐CD38 monoclonal antibodies induces a durable response to SARS‐CoV ‐2 vaccination in patients with plasma cell dyscrasia
2022 · Toshiki Terao, Takashi Naduka, et al. · British Journal of Haematology · 14
Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-Versus-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide
2021 · Toshiki Terao, Ken-ichi Matsuoka, et al. · Frontiers in Oncology · 13
PDF
Baseline total lesion glycolysis combined with interim positron emission tomography‐computed tomography is a robust predictor of outcome in patients with peripheral T‐cell lymphoma
2020 · Akihiro Kitadate, Kentaro Narita, et al. · Cancer Medicine · 13
PDF
Evaluation of the safety and efficacy of daratumumab outside of clinical trials
2019 · Hiroki Kobayashi, Takafumi Tsushima, et al. · International Journal of Hematology · 13
3D CNN-based Deep Learning Model-based Explanatory Prognostication in Patients with Multiple Myeloma using Whole-body MRI
2024 · Kento Morita, Shigehiro Karashima, et al. · Journal of Medical Systems · 12
Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case report
2021 · Kyosuke Seguchi, Kei Nakashima, et al. · Respiratory Medicine Case Reports · 12
PDF
Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study
2021 · Masatoshi Matsunami, Tomo Suzuki, et al. · Clinical and Experimental Nephrology · 11
PDF
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir era
2024 · Toshiki Terao, Ken-ichi Matsuoka, et al. · Bone Marrow Transplantation · 10
Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
2021 · Takafumi Tsushima, Tomo Suzuki, et al. · BMC Nephrology · 10
PDF
Works count: 92
Citation count: 715
H-index: 14
I10-index: 25
Year
Topic
Type